Company profile · Kuopio, Finland

Bone Index Finland Ltd.

Point-of-Care Pulse-Echo Ultrasound, Osteoporosis Diagnosis, and Bone Density Testing · Medical-device manufacturing

Kuopio point-of-care osteoporosis diagnostic developer with named CEO, FDA 510(k) clearance, CE MDR marking, and a 2024 financing round.

Lead
Janne Karjalainen (verified ↗)
Address
Savilahdentie 14, 70700 Kuopio, Finland (source ↗)
Compliance
FDA 510(k) clearance · CE MDR · ISO 13485 presumed for device manufacture
Last reviewed
24 Apr 2026 (1mo ago)
Scale
Medical-device manufacturing
Capabilities
Point-of-Care Ultrasound R&D · Bone Density Algorithm Development · EU and US Commercialization
Founded
2011
Headcount
1-10
LinkedIn
Company page (open ↗)
Site and address
Clinical profileSTATUS: VERIFIED APRIL 2026

Janne Karjalainen

Chief Executive Officer

Check official leadership source
Full addressSavilahdentie 14, 70700 Kuopio, Finland
Site coordinatesVerification evidence is still being completed.
Review cycle24 April 2026
Physical site source

RocketReach corporate record for Bone Index Finland Ltd. at Savilahdentie 14, Kuopio.

Open source
Operating profile

Medical-device manufacturing

Kuopio, Finland. Point-of-Care Pulse-Echo Ultrasound, Osteoporosis Diagnosis, and Bone Density Testing. Review completed on 24 Apr 2026.

2026 technical specializationPoint-of-Care Pulse-Echo Ultrasound, Osteoporosis Diagnosis, and Bone Density Testing
Core capabilities
Point-of-Care Ultrasound R&DBone Density Algorithm DevelopmentEU and US Commercialization
Governance

Fimea and FDA for medical-device oversight

FDA 510(k) clearance, CE MDR, ISO 13485 presumed for device manufacture

Editorial note

Point-of-Care Pulse-Echo Ultrasound, Osteoporosis Diagnosis, and Bone Density Testing

Kuopio point-of-care osteoporosis diagnostic developer with named CEO, FDA 510(k) clearance, CE MDR marking, and a 2024 financing round.

Editorial note

Bone Index is a Kuopio diagnostic medical-device company with a named CEO, FDA 510(k) clearance, and CE MDR marking, plus a 2024 financing round on record.

FULL TRUST REVIEW COMPLETE
Shown only when all seven trust checks are fully mapped in the directory.
Current review cycleApril 2026Last reviewed: 24 April 2026
Capabilities

Core capabilities

Primary declared technical activities and areas of operating focus.

Point-of-Care Ultrasound R&D
Bone Density Algorithm Development
EU and US Commercialization
Verification source dossier

Verification source dossier

Official source set used to support leadership, physical-site, certification, and watch-note evidence.

Leadership evidenceBone Index LinkedIn company page listing Janne Karjalainen as CEO.Source origin: linkedin.comOpen source
Supporting evidenceFinSMEs 2024 financing round coverage of Bone Index.Source origin: finsmes.comOpen source
Physical-site evidenceRocketReach corporate record for Bone Index Finland Ltd. at Savilahdentie 14, Kuopio.Source origin: rocketreach.coOpen source
Infrastructure

Declared infrastructure

Bindex point-of-care ultrasound device
Algorithm development
Clinical validation
Regulatory posture

Quality system coverage

GMP / GLP / ISO-13485 / FDA-Inspected are global quality-system standards. "Verified active" means the directory confirmed the certification is current; "Review in progress" means the cert status is currently being re-verified.

GMP
REVIEW IN PROGRESS 2026
GLP
REVIEW IN PROGRESS 2026
ISO-13485
VERIFIED ACTIVE 2026
FDA-Inspected
VERIFIED ACTIVE 2026
Verification history

Verification history

24 Apr 2026: Executive identity confirmed via official management disclosure.
24 Apr 2026: Full trust review completed.
FAQ

Frequently asked questions

Where is Bone Index Finland Ltd. located?
Bone Index Finland Ltd. operates from Savilahdentie 14, 70700 Kuopio, Finland, Kuopio, Finland.
Who runs Bone Index Finland Ltd.?
Bone Index Finland Ltd. is led by Janne Karjalainen, Chief Executive Officer. Verified 24 Apr 2026.
What certifications does Bone Index Finland Ltd. hold?
Bone Index Finland Ltd. is documented under FDA 510(k) clearance, CE MDR, ISO 13485 presumed for device manufacture.
What does Bone Index Finland Ltd. do?
Kuopio point-of-care osteoporosis diagnostic developer with named CEO, FDA 510(k) clearance, CE MDR marking, and a 2024 financing round. Core capabilities: Point-of-Care Ultrasound R&D, Bone Density Algorithm Development, EU and US Commercialization.
Editorial context

Related technical briefs

Briefs that name Kuopio as a covered market or city.